Abstract: The current invention relates to a polymer-lipid microemulsion delivery system for drugs or antiviral compounds used in the treatment or inhibition of viral Acute Respiratory Distress Syndromes (ARDS), a process for producing the microemulsion delivery system, and to methods of use of the microemulsion delivery system for the treatment of ARDS.

Abstract: The invention provides a method of diagnosing tuberculosis by using a novel antibody biomarker capturing vehicle, activating a screen-printed electrode using chemical and mechanical polishing, and immobilising mycolic acid antigen biomarkers on the activated electrode. The novel antibody biomarker capturing vehicle is produced by introducing isolated mycolic acid antigens of tuberculous mycobacterial origin onto an outer surface of a nanoparticle such that the mycolic acid antigens are presented as antibody biomarker capturing agents. The solvent resistant screen-printed electrode is activated by both chemically and mechanically polishing the electrode. The mycolic acid antigens are immobilised on the activated electrode by incubating the activated electrode with a mycolic acid-dimethylformamide solution to allow mycolic acid antigens to adsorb onto the activated electrode.